Nov 27, 2023, 17:33
Rescuing drugs and the multi-stakeholder approach for drug development – ACCELERATE Multi-Stakeholder Platform
ACCELERATE Multi-Stakeholder Platform shared on their LinkedIn page:
“Better therapies for childhood cancer remain an unmet need, to improve the dismal prognosis of certain malignancies and to reduce the burden of toxicity to all patients. The multi-stakeholder approach for drug development has the advantage of conveying a consensus between academia, patient advocates and very importantly industry itself.
Read the new ACCELERATE article today to learn about rescuing drugs and the multi-stakeholder approach for drug development here.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 22:09
Nov 22, 2024, 21:56
Nov 22, 2024, 21:35
Nov 22, 2024, 21:11
Nov 22, 2024, 21:07
Nov 22, 2024, 20:44